Post-Acute COVID-19 Syndrome
82
17
23
34
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.2%
1 terminated out of 82 trials
97.1%
+10.6% vs benchmark
5%
4 trials in Phase 3/4
9%
3 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 34 completed trials
Clinical Trials (82)
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Probiotic Use for Recovery Enhancement From Long COVID-19
Attention, Memory and Quality of Life in Post-COVID-19 Adults
Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized Controlled Study
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
Cognitive Rehabilitation Therapy for COVID-19
Education of Medical Staff to Post Acute Covid susTained sYmptoms
Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
Diaphragmatic Breathing Exercises With KOTS Currents in Patients With Long COVID
A Study of Positive Emotions With Long COVID-19
Brain-Training Treatment for Long COVID in Older Adults
Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV)
Harnessing Optimism and Perseverance in the Face of Long COVID-Español
Long COVID Brain Fog: Cognitive Rehabilitation Trial
Exercise Training Using an App on Physical Cardiovascular Function Individuals With Post-covid-19 Syndrome
Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.
Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction
Amantadine Therapy for Cognitive Impairment in Long COVID
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research